|3Nov 14, 4:34 PM ET

Evelyn Potter Rose Survivor's Trust 3

3 · REATA PHARMACEUTICALS INC · Filed Nov 14, 2018

Insider Transaction Report

Form 3
Period: 2018-11-13
Holdings
  • Class A common stock

    879,281
  • Class B common stock

    Class A common stock (1,877,998 underlying)
Footnotes (1)
  • [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis. The conversion right of the Class B common stock has no expiration date.

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION